In patients who do not meet the World Health Organization (WHO) criteria for overt polycythaemia vera (PV), a diagnosis of masked PV (mPV) can be determined. A fraction of mPV patients may display thrombocytosis, thus mimicking essential thrombocythaemia (ET). No previous studies have examined clinical outcomes of mPV among young JAK2-mutated patients. We analysed a retrospective cohort of 538
A lower intensity of treatment may underlie the increased risk of thrombosis in young patients with masked polycythaemia vera / Lussana, F; Carobbio, A; Randi, Ml; Elena, C; Rumi, E; Finazzi, G; Bertozzi, I; Pieri, L; Ruggeri, M; Palandri, F; Polverelli, N; Elli, E; Tieghi, A; Iurlo, A; Ruella, M; Cazzola, M; Rambaldi, A; Vannucchi, Am; Barbui, T. - In: BRITISH JOURNAL OF HAEMATOLOGY. - ISSN 1365-2141. - 167:4(2014), pp. 541-546. [10.1111/bjh.13080]
A lower intensity of treatment may underlie the increased risk of thrombosis in young patients with masked polycythaemia vera
Carobbio A;
2014
Abstract
In patients who do not meet the World Health Organization (WHO) criteria for overt polycythaemia vera (PV), a diagnosis of masked PV (mPV) can be determined. A fraction of mPV patients may display thrombocytosis, thus mimicking essential thrombocythaemia (ET). No previous studies have examined clinical outcomes of mPV among young JAK2-mutated patients. We analysed a retrospective cohort of 538
Pubblicazioni consigliate
I metadati presenti in IRIS UNIMORE sono rilasciati con licenza Creative Commons CC0 1.0 Universal, mentre i file delle pubblicazioni sono rilasciati con licenza Attribuzione 4.0 Internazionale (CC BY 4.0), salvo diversa indicazione.
In caso di violazione di copyright, contattare Supporto Iris
